alarm, enuresis
npa pty ltd t/a cura1 -
activecare - alarm, emergency assistance
npa pty ltd t/a cura1 -
activecare - alarm, emergency assistance
npa pty ltd t/a cura1 -
activecare - alarm, emergency assistance
npa pty ltd t/a cura1 -
ensign system - alarm, emergency assistance
npa pty ltd t/a cura1 -
amitriptyline expharma 25 mg filmomhulde tabletten
extractumpharma ltd. megyeri út 64 1044 budapest (hongarije) - amitriptylinehydrochloride 28,3 mg/stuk samenstelling overeenkomend met ; amitriptyline 25 mg/stuk - filmomhulde tablet - cellulose, gepoederd (e 460(ii)) ; croscarmellose natrium (e 468) ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; lactose 1-water ; macrogol 3350 ; magnesiumstearaat (e 470b) ; maÏszetmeel ; polyvinylalcohol (e 1203) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171), cellulose, gepoederd (e 460) ; croscarmellose natrium (e 468) ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; lactose 1-water ; macrogol 3350 ; magnesiumstearaat (e 470b) ; maÏszetmeel ; polyvinylalcohol (e1203) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171), ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; lactose 1-water ; macrogol 3350 ; magnesiumstearaat (e 470b) ; maÏszetmeel ; polyvinylalcohol, gedeeltelijk gehydrolyseerd (e1203) ; povidon k 25 (e 1201) ; talk (e 553 b) ; titaandioxide (e 171), - amitriptyline
lynparza 50 mg
astra zeneca (israel) ltd - olaparib - hard capsule - olaparib 50 mg - olaparib - lynparza is indicated as monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed brca-mutated (germline and/or somatic) high grade serous epithelial ovarian cancer, (including fallopian tube, or primary peritoneal) cancer who are in response (complete response or partial response) to platinum-based chemotherapy.
denpax
alphapharm pty ltd - fentanyl -
fenpatch
medis pharma pty ltd - fentanyl -
onpattro
alnylam netherlands b.v. - patisiran sodu - amyloidoza, hotel rodzinny - inne leki na układ nerwowy - onpattro jest wskazany do leczenia dziedzicznych транстиретина pośredniczącego amyloidozy (hattr amyloidoza) u dorosłych pacjentów z etapu 1 lub 2 fazy polineuropatii.